Company Monitoring Page for Gilead

latest headlines for company on cafepharma

Achillion, Vertex rally on Gilead's woes
Marketwatch
Fri, 02/17/12 - 01:17 pm
Tags:
Vertex, Gilead, Achillion, GS-7977, protease inhibitors, hepatitis C
Gilead Suffers First Hep C Drug Setback
TheStreet.com
Fri, 02/17/12 - 09:05 am
Tags:
Gilead, hepatitis C, GS-7977
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
Tags:
BIO CEO Conference, Pfizer, Indenix, Keryx, Delcath, Oncothyreon, Acorda Therapeutics, Human Genome Sciences, Gilead
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
Seeking Alpha
Tue, 02/14/12 - 11:19 am
Tags:
Alexion, Gilead, Amgen, Soliris, Biogen Idec
Gilead: FDA Fast Tracks Review Of HIV Drug Truvada
Morningstar
Tue, 02/14/12 - 11:02 am
Tags:
Truvada, fast track, FDA, Gilead, HIV
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Mon, 02/13/12 - 10:25 am
Tags:
Vertex, hepatitis C, Gilead
There’s no Stopping Gilead Sciences
Motley Fool
Mon, 02/6/12 - 09:45 am
Tags:
Gilead
Idenix Falls Casualty to Gilead Hep C Hoopla
TheStreet.com
Fri, 02/3/12 - 11:56 am
Tags:
Gilead, hepatitis C, Idenix
Gilead Sciences 4Q profit rises on HIV drug sales
Yahoo/AP
Fri, 02/3/12 - 09:47 am
Tags:
earnings, HIV, Gilead
Gilead Stock, In Top Group, Slips Before Earnings
Investors.com
Thu, 02/2/12 - 11:56 am
Tags:
Gilead, earnings
Which Big Biotech Is the Best Bet?
Motley Fool
Tue, 01/31/12 - 08:01 am
Tags:
Gilead, Amgen, Celgene, Biogen Idec
Gilead Sciences Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Mon, 01/30/12 - 03:51 pm
Tags:
Gilead, earnings
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Fri, 01/27/12 - 11:08 am
Tags:
Alexion, Amgen, Ariad, Biogen Idec, Bristol-Myers Squibb, Celgene, Gilead, Illumina, Inhibitex, Vertex Pharmaceuticals
Gilead not immune to concern over Truvada’s wider HIV use
FT.com
Tue, 01/24/12 - 11:22 am
Tags:
HIV, Truvada, Gilead
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
Tags:
SOMA, Regeneron, Vertex, Gilead, GSK, Biocryst, Dendreon, InterMune
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Tags:
Abbott Laboratories, Achillion, Alexion, Bristol-Myers Squibb, Gilead, GSK, Human Genome Sciences, Indenix, Inhibitex, JNJ, Pfizer, Vertex, Pharmasset
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thu, 01/12/12 - 08:29 am
Tags:
M&A, Pharmasset, Gilead
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
Tags:
hepatitis C, Anadys, Roche, Gilead, Pharmasset, Bristol-Myers Squibb, Inhibitex
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
Tags:
hepatitis C, Inhibitex, Bristol-Myers Squibb, Gilead, Pharmasset, M&A
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Mon, 01/9/12 - 10:39 am
Tags:
Abbott Laboratories, Amgen, Biogen Idec, Gilead, Celgene, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, Pfizer, ETFs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.